Form 4: Elanco Animal Health Director R. David Hoover Increases Stake with $322,808 Purchase

Sentiment:

SEC Form 4 Filing


Director R. David Hoover of Elanco Animal Health Inc. [ELAN] recently acquired 20,000 shares of common stock at a price of $16.1404 per share.

Summary

  • On March 6, 2024, R. David Hoover, a director of Elanco Animal Health Inc., purchased 20,000 shares of the company's common stock.
  • The purchase price was $16.1404 per share, totaling $322,808.
  • Following the transaction, Hoover directly owns 78,290 shares and indirectly owns 185,000 shares through a revocable trust and 15,920 shares through the Suzanne A. Hoover Revocable Trust.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the director's purchase of shares, indicating confidence in the company. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

  • The director's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive signal, suggesting that those with the most knowledge of the company's prospects are optimistic about its future. However, it's important to consider the overall context, including the size of the purchase relative to the director's existing holdings and the company's recent performance.

Key Dates

DateDescription
03/06/2024Date of the stock purchase transaction.
03/08/2024Date of signature for the SEC Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.